# FDA Inspection 646917 - SERIPHARM - January 29, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/seripharm/f930ba8e-c8ba-44b7-8db7-262697e6a87e/
Source feed: FDA_Inspections

> FDA Inspection 646917 for SERIPHARM on January 29, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 646917
- Company Name: SERIPHARM
- Inspection Date: 2010-01-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1273405 - 2021-03-12](https://www.globalkeysolutions.net/api/records/fda_inspections/seripharm/046b3ab9-6848-453f-8528-c2e2e36fac00/)
- [FDA Inspection 1068502 - 2018-03-15](https://www.globalkeysolutions.net/api/records/fda_inspections/seripharm/a59f9cab-015b-43a5-ae9e-c749f14e8b08/)
- [FDA Inspection 972558 - 2016-05-06](https://www.globalkeysolutions.net/api/records/fda_inspections/seripharm/733444d4-11e1-48f5-885c-986a5379c6af/)
- [FDA Inspection 836916 - 2013-06-06](https://www.globalkeysolutions.net/api/records/fda_inspections/seripharm/23cd6c9a-13fa-4b32-844f-fcf0d7e31b1e/)

Company: https://www.globalkeysolutions.net/companies/seripharm/b5349d82-bf7e-4e82-b09e-2c134d55df09

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c